financetom
Business
financetom
/
Business
/
Unilever beats third-quarter underlying sales estimate
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Unilever beats third-quarter underlying sales estimate
Oct 31, 2024 2:08 AM

LONDON (Reuters) -Unilever achieved slightly better than expected underlying quarterly sales after winning back more shoppers with product innovations and slower price increases.

The consumer goods giant said on Thursday it was keeping its full-year outlook for 3-5% underlying sales growth and an underlying operating margin of at least 18%.

The maker of Dove soap and Hellmann's condiments reported a 4.5% rise in third-quarter underlying sales, beating analysts' average forecast of a 4.2% increase, according to a company-provided consensus.

Underlying price growth for the quarter was 0.9% while underlying volume sales growth was 3.5%. Analysts had expected a 1% increase in prices and a 3.2% rise in volumes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
StubHub Prices IPO at $23.50 per Share
StubHub Prices IPO at $23.50 per Share
Sep 17, 2025
03:41 AM EDT, 09/17/2025 (MT Newswires) -- StubHub ( STUB ) said late Tuesday it has priced an initial public offering of about 34 million shares at $23.50 per share. Underwriters have been granted a 30-day option to purchase up to about 5.1 million additional shares. The shares are expected to begin trading on the New York Stock Exchange this...
AstraZeneca's asthma drug fails 'smoker's lung' study
AstraZeneca's asthma drug fails 'smoker's lung' study
Sep 17, 2025
Sept 17 (Reuters) - AstraZeneca ( AZN ) said on Wednesday its asthma drug Fasenra failed to control the rate of flare-ups in patients with chronic obstructive pulmonary disease (COPD) in a late-stage study, in a setback to efforts to help tackle a severe lung disease. The drugmaker said Fasenra did not meet the primary endpoint in COPD patients compared...
Peloton Interactive Insider Sold Shares Worth $1,000,449, According to a Recent SEC Filing
Peloton Interactive Insider Sold Shares Worth $1,000,449, According to a Recent SEC Filing
Sep 17, 2025
03:41 AM EDT, 09/17/2025 (MT Newswires) -- Jennifer Cunningham Cotter, Chief Content Officer, on September 14, 2025, sold 128,429 shares in Peloton Interactive ( PTON ) for $1,000,449. Following the Form 4 filing with the SEC, Cotter has control over a total of 210,504 Class A common shares of the company, with 210,504 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1639825/000194676125000004/xslF345X05/wk-form4_1758069368.xml ...
Oracle Insider Sold Shares Worth $3,519,000, According to a Recent SEC Filing
Oracle Insider Sold Shares Worth $3,519,000, According to a Recent SEC Filing
Sep 17, 2025
03:41 AM EDT, 09/17/2025 (MT Newswires) -- William G Parrett, Director, on September 12, 2025, sold 11,500 shares in Oracle (ORCL) for $3,519,000. Following the Form 4 filing with the SEC, Parrett has control over a total of 27,075 common shares of the company, with 9,311 shares held directly and 17,764 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1341439/000134143925000006/xslF345X05/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved